Loading...
•
Jun 30, 2020
Teladoc Q2 2020 Earnings Report
Reported strong financial results, citing sustained momentum across its diversified portfolio.
Key Takeaways
Teladoc Health reported an 85% year-over-year revenue growth to $241.0 million for Q2 2020, with total visits increasing by 203% to 2.8 million. The company issued Q3 guidance, raised full-year expectations, and provided a preliminary 2021 revenue growth outlook.
Q2 revenue grew 85% year-over-year to $241.0 million.
Total visits increased 203% year-over-year to 2.8 million.
InTouch Health acquisition solidified leadership in hospital-based telemedicine and is projected to grow over 35% in 2020.
Utilization stabilized at a level 40 percent higher than before COVID.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Teladoc Health provided guidance based on current market conditions and expectations. For the third-quarter 2020, the company expects total revenue to be in the range of $275 million to $285 million and total visits to be between 2.5 million and 2.7 million.
Positive Outlook
- Total revenue to be in the range of $275 million to $285 million.
- EBITDA to be in the range of $(3) million to $1 million.
- Adjusted EBITDA to be in the range of $27 million to $31 million.
- Total U.S. paid membership to be approximately 50 million to 51 million members and visit-fee-only access to be available to approximately 21 to 22 million individuals, including 2 to 3 million members on a temporary basis.
- Total visits to be between 2.5 million and 2.7 million.
Challenges Ahead
- Net loss per share, based on 83.4 million weighted average shares outstanding, to be between $(0.35) and $(0.30).
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...